DEXTROSE IN LACTATED RINGER'S IN. Key specifications include administration: INTRAVENOUS, special_features: FOR THE MMESO STANDARDIZED JOINT PRODUCT OF CHOICE, USE CAGE 11171, AND PART NUMBER L7500, NDC00264-7750-00, primary_container_type: BAG, PLASTIC, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 12, primary_container_content_quantity: 1000.000 MILLILITERS. This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-330-6250, indicating validated use in U.S.
government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | FOR THE MMESO STANDARDIZED JOINT PRODUCT OF CHOICE, USE CAGE 11171, AND PART NUMBER L7500, NDC00264-7750-00 |
| primary_container_type | BAG, PLASTIC |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 12 |
| primary_container_content_quantity | 1000.000 MILLILITERS |
| active_medicament_medicinal_strength | 5.000 PERCENTAGE, W/V DEXTROSE IN LACTATED RINGER'S ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | DEXTROSE IN LACTATED RINGER'S INJECTION 5% 1000ML BAG 12S |
| NSN | 6505-01-330-6250 |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | BAG, PLASTIC |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DEXTROSE IN LACTATED RINGER'S INJECTION 5% 1000ML BAG 12S |
| TOTAL PRIMARY CONTAINER QUANTITY | 12 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 PERCENTAGE, W/V DEXTROSE IN LACTATED RINGER'S ACTIVE INGREDIENT |